Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Gains from Investment Securities (2019 - 2025)

Fate Therapeutics' Gains from Investment Securities history spans 11 years, with the latest figure at -$45000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$45000.0; the TTM value through Dec 2025 reached -$987000.0, up 1.69%, while the annual FY2025 figure was -$9000.0, 99.04% up from the prior year.
  • Gains from Investment Securities reached -$45000.0 in Q4 2025 per FATE's latest filing, up from -$942000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.1 million in Q4 2021 to a low of -$942000.0 in Q3 2024.
  • Average Gains from Investment Securities over 5 years is $1.1 million, with a median of $102000.0 recorded in 2021.
  • The largest YoY upside for Gains from Investment Securities was 493.77% in 2021 against a maximum downside of 96.98% in 2021.
  • A 5-year view of Gains from Investment Securities shows it stood at $7.1 million in 2021, then plummeted by 97.68% to $164000.0 in 2022, then plummeted by 137.8% to -$62000.0 in 2023, then tumbled by 1419.35% to -$942000.0 in 2024, then soared by 95.22% to -$45000.0 in 2025.
  • Per Business Quant, the three most recent readings for FATE's Gains from Investment Securities are -$45000.0 (Q4 2025), -$942000.0 (Q3 2024), and -$62000.0 (Q4 2023).